☰

James B. Whitney, Ph.D. - Publications

Affiliations: 
2004 McGill University, Montreal, QC, Canada 
Area:
Microbiology Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lee J, Whitney JB. Immune checkpoint inhibition as a therapeutic strategy for HIV eradication: current insights and future directions. Current Opinion in Hiv and Aids. PMID 38747727 DOI: 10.1097/COH.0000000000000863  0.391
2024 Lim SY, Lee J, Osuna CE, Vikhe P, Schalk DR, Chen E, Fray E, Kumar M, Schultz-Darken N, Rakasz E, Capuano S, Ladd RA, Gil HM, Evans DT, Jeng EK, ... ... Whitney JB, et al. Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science (New York, N.Y.). eadf7966. PMID 38422185 DOI: 10.1126/science.adf7966  0.384
2020 Toledo NPL, Li H, Omange RW, Dacoba TG, Crecente-Campo J, Schalk D, Kashem MA, Rakasz E, Schultz-Darken N, Li Q, Whitney JB, Alonso MJ, Plummer FA, Luo M. Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens. Frontiers in Immunology. 11: 1935. PMID 32983121 DOI: 10.3389/Fimmu.2020.01935  0.373
2020 Li H, Omange RW, Liang B, Toledo N, Hai Y, Liu LR, Schalk D, Crecente-Campo J, Dacoba TG, Lambe AB, Lim SY, Li L, Kashem MA, Wan Y, Correia-Pinto JF, ... ... Whitney JB, et al. Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection. The Journal of Clinical Investigation. PMID 32853182 DOI: 10.1172/Jci138728  0.416
2020 Lim SY, Osuna CE, Best K, Taylor R, Chen E, Yoon G, Kublin JL, Schalk D, Schultz-Darken N, Capuano S, Safronetz D, Luo M, MacLennan S, Mathis A, Babu YS, ... ... Whitney JB, et al. A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques. Science Translational Medicine. 12. PMID 32522808 DOI: 10.1126/Scitranslmed.Aau9135  0.463
2020 Blum FC, Hardy BL, Bishop-Lilly KA, Frey KG, Hamilton T, Whitney JB, Lewis MG, Merrell DS, Mattapallil JJ. Microbial Dysbiosis During Simian Immunodeficiency Virus Infection is Partially Reverted with Combination Anti-retroviral Therapy. Scientific Reports. 10: 6387. PMID 32286417 DOI: 10.1038/S41598-020-63196-0  0.481
2018 Whitney JB, Lim SY, Osuna CE, Kublin JL, Chen E, Yoon G, Liu PT, Abbink P, Borducci EN, Hill A, Lewis MG, Geleziunas R, Robb ML, Michael NL, Barouch DH. Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy. Nature Communications. 9: 5429. PMID 30575753 DOI: 10.1038/S41467-018-07881-9  0.452
2018 Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM, Ackerman ME, Jones RB, Nixon DF, Whitney JB. Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. PMID 30315222 DOI: 10.1038/S41586-018-0611-3  0.331
2018 Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM, Ackerman ME, Jones RB, Nixon DF, Whitney JB. Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. 561: E20-E28. PMID 30232424 DOI: 10.1038/S41586-018-0495-2  0.38
2018 Li H, Hai Y, Lim SY, Toledo N, Crecente-Campo J, Schalk D, Li L, Omange RW, Dacoba TG, Liu LR, Kashem MA, Wan Y, Liang B, Li Q, Rakasz E, ... ... Whitney JB, et al. Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques. Plos One. 13: e0202997. PMID 30153293 DOI: 10.1371/Journal.Pone.0202997  0.414
2018 Whitney JB, Brad Jones R. In Vitro and In Vivo Models of HIV Latency. Advances in Experimental Medicine and Biology. 1075: 241-263. PMID 30030796 DOI: 10.1007/978-981-13-0484-2_10  0.427
2018 Bhattacharyya M, Whitney JB, Seaman M, Barouch DH, Penaloza-MacMaster P. T cell subset differentiation and antibody responses following antiretroviral therapy during SIV infection. Immunology. PMID 30014618 DOI: 10.1111/Imm.12985  0.515
2018 Lim SY, Osuna CE, Hraber PT, Hesselgesser J, Gerold JM, Barnes TL, Sanisetty S, Seaman MS, Lewis MG, Geleziunas R, Miller MD, Cihlar T, Lee WA, Hill AL, Whitney JB. TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy. Science Translational Medicine. 10. PMID 29720451 DOI: 10.1126/Scitranslmed.Aao4521  0.499
2018 Webb GM, Li S, Mwakalundwa G, Folkvord JM, Greene JM, Reed JS, Stanton JJ, Legasse AW, Hobbs T, Martin LD, Park BS, Whitney JB, Jeng EK, Wong HC, Nixon DF, et al. The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles. Blood Advances. 2: 76-84. PMID 29365313 DOI: 10.1182/Bloodadvances.2017012971  0.428
2017 Osuna CE, Whitney JB. Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development. The Journal of Infectious Diseases. 216: S928-S934. PMID 29267926 DOI: 10.1093/Infdis/Jix540  0.502
2017 Li H, Nykoluk M, Li L, Liu LR, Omange RW, Soule G, Schroeder LT, Toledo N, Kashem MA, Correia-Pinto JF, Liang B, Schultz-Darken N, Alonso MJ, Whitney JB, Plummer FA, et al. Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques. Plos One. 12: e0186079. PMID 28982126 DOI: 10.1371/Journal.Pone.0186079  0.36
2017 Julg B, Liu PT, Wagh K, Fischer WM, Abbink P, Mercado NB, Whitney JB, Nkolola JP, McMahan K, Tartaglia LJ, Borducchi EN, Khatiwada S, Kamath M, LeSuer JA, Seaman MS, et al. Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Science Translational Medicine. 9. PMID 28931655 DOI: 10.1126/Scitranslmed.Aao4235  0.493
2017 Kublin JL, Whitney JB. Zika Virus Research Models. Virus Research. PMID 28811170 DOI: 10.1016/J.Virusres.2017.07.025  0.452
2017 Best K, Guedj J, Madelain V, de Lamballerie X, Lim SY, Osuna CE, Whitney JB, Perelson AS. Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies. Proceedings of the National Academy of Sciences of the United States of America. PMID 28765371 DOI: 10.1073/Pnas.1704011114  0.415
2017 Li H, Omange RW, Czarnecki C, Correia-Pinto JF, Crecente-Campo J, Richmond M, Li L, Schultz-Darken N, Alonso MJ, Whitney JB, Plummer FA, Luo M. Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection. Journal of Medical Primatology. 46: 137-143. PMID 28748659 DOI: 10.1111/Jmp.12300  0.438
2017 Lim S, Osuna C, Lakritz J, Chen E, Yoon G, Taylor R, MacLennan S, Leonard M, Giuliano E, Mathis A, Berger E, Babu Y, Sheridan W, Whitney J. Galidesivir, a direct-acting antiviral drug, abrogates viremia in Rhesus macaques challenged with Zika virus Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx162.129  0.421
2017 Osuna CE, Apps R, Lim S-, Kublin JL, Thomas R, Chen E, Yoon G, Huang SH, Chan D, Truong R, Ren Y, Bachtel ND, Ackerman ME, Ananworanich J, Barouch DH, ... ... Whitney JB, et al. CD32 does not mark the HIV-1/SIV latent reservoir Journal of Virus Eradication. 3: 2. DOI: 10.1016/S2055-6640(20)30524-0  0.363
2016 Osuna CE, Lim SY, Deleage C, Griffin BD, Stein D, Schroeder LT, Omage R, Best K, Luo M, Hraber PT, Andersen-Elyard H, Ojeda EF, Huang S, Vanlandingham DL, Higgs S, ... ... Whitney JB, et al. Zika viral dynamics and shedding in rhesus and cynomolgus macaques. Nature Medicine. PMID 27694931 DOI: 10.1038/Nm.4206  0.469
2016 Moldt B, Le KM, Carnathan DG, Whitney JB, Schultz N, Lewis MG, Borducchi EN, Smith KM, Mackel JJ, Sweat SL, Hodges AP, Godzik A, Parren PW, Silvestri G, Barouch DH, et al. Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques. Aids (London, England). 30: 1543-1551. PMID 27243773 DOI: 10.1097/Qad.0000000000001102  0.42
2016 Jones RB, Mueller S, O'Connor R, Rimpel K, Sloan DD, Karel D, Wong HC, Jeng EK, Thomas AS, Whitney JB, Lim SY, Kovacs C, Benko E, Karandish S, Huang SH, et al. A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. Plos Pathogens. 12: e1005545. PMID 27082643 DOI: 10.1371/Journal.Ppat.1005545  0.38
2016 Tartaglia LJ, Chang HW, Lee BC, Abbink P, Ng'ang'a D, Boyd M, Lavine CL, Lim SY, Sanisetty S, Whitney JB, Seaman MS, Rolland M, Tovanabutra S, Ananworanich J, Robb ML, et al. Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences. Plos Pathogens. 12: e1005431. PMID 26849216 DOI: 10.1371/Journal.Ppat.1005431  0.507
2016 Lim S, Osuna C, Taylor R, Mathis A, Kamath V, Berger E, Babu YS, Sheridan W, Whitney J. BCX4430, a Broad-Spectrum Adenosine Analog Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus. Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw195.05  0.413
2015 Barouch DH, Alter G, Broge T, Linde C, Ackerman ME, Brown EP, Borducchi EN, Smith KM, Nkolola JP, Liu J, Shields J, Parenteau L, Whitney JB, Abbink P, Ng'ang'a DM, et al. Protective efficacy of adenovirus-protein vaccines against SIV challenges in rhesus monkeys. Science (New York, N.Y.). PMID 26138104 DOI: 10.1126/Science.Aab3886  0.434
2015 Chang HW, Tartaglia LJ, Whitney JB, Lim SY, Sanisetty S, Lavine CL, Seaman MS, Rademeyer C, Williamson C, Ellingson-Strouss K, Stamatatos L, Kublin J, Barouch DH. Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocks. Journal of Virology. 89: 1965-74. PMID 25473043 DOI: 10.1128/Jvi.03279-14  0.522
2014 Whitney JB, Hill AL, Sanisetty S, Penaloza-MacMaster P, Liu J, Shetty M, Parenteau L, Cabral C, Shields J, Blackmore S, Smith JY, Brinkman AL, Peter LE, Mathew SI, Smith KM, et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature. 512: 74-7. PMID 25042999 DOI: 10.1038/Nature13594  0.505
2013 Barouch DH, Whitney JB, Moldt B, Klein F, Oliveira TY, Liu J, Stephenson KE, Chang HW, Shekhar K, Gupta S, Nkolola JP, Seaman MS, Smith KM, Borducchi EN, Cabral C, et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature. 503: 224-8. PMID 24172905 DOI: 10.1038/Nature12744  0.441
2012 Asmal M, Whitney JB, Luedemann C, Carville A, Steen R, Letvin NL, Geiben-Lynn R. In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes. Plos One. 7: e48234. PMID 23133620 DOI: 10.1371/Journal.Pone.0048234  0.423
2011 Whitney JB, Lim SY, Wainberg MA. Evolutionary mechanisms of retroviral persistence. Aids Reviews. 13: 234-9. PMID 21975359  0.532
2011 Yeh WW, Rao SS, Lim SY, Zhang J, Hraber PT, Brassard LM, Luedemann C, Todd JP, Dodson A, Shen L, Buzby AP, Whitney JB, Korber BT, Nabel GJ, Mascola JR, et al. The TRIM5 gene modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys. Journal of Virology. 85: 10389-98. PMID 21775457 DOI: 10.1128/Jvi.00854-11  0.519
2011 Letvin NL, Rao SS, Montefiori DC, Seaman MS, Sun Y, Lim SY, Yeh WW, Asmal M, Gelman RS, Shen L, Whitney JB, Seoighe C, Lacerda M, Keating S, Norris PJ, et al. Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Science Translational Medicine. 3: 81ra36. PMID 21543722 DOI: 10.1126/Scitranslmed.3002351  0.484
2011 Whitney JB, Asmal M, Geiben-Lynn R. Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication. Plos One. 6: e18589. PMID 21533265 DOI: 10.1371/Journal.Pone.0018589  0.467
2011 Whitney JB, Hraber PT, Luedemann C, Giorgi EE, Daniels MG, Bhattacharya T, Rao SS, Mascola JR, Nabel GJ, Korber BT, Letvin NL. Genital tract sequestration of SIV following acute infection. Plos Pathogens. 7: e1001293. PMID 21379569 DOI: 10.1371/Journal.Ppat.1001293  0.506
2011 Whitney JB, Mirshahidi S, Lim SY, Goins L, Ibegbu CC, Anderson DC, Raybourne RB, Frankel FR, Lieberman J, Ruprecht RM. Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV. Journal of Immune Based Therapies and Vaccines. 9: 2. PMID 21244649 DOI: 10.1186/1476-8518-9-2  0.424
2011 Yeh W, Rao S, Lim S, Zhang J, Hraber P, Brassard L, Luedemann C, Todd JP, Dodson A, Shen L, Buzby A, Whitney J, Korber B, Nabel G, Mascola J, et al. TRIM5 modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys F1000research. 2. DOI: 10.7490/F1000Research.1089571.1  0.461
2010 Masek-Hammerman K, Li H, Liu J, Abbink P, La Porte A, O'Brien KL, Whitney JB, Carville A, Mansfield KG, Barouch DH. Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. Journal of Virology. 84: 9810-6. PMID 20686023 DOI: 10.1128/Jvi.01157-10  0.403
2010 Lim SY, Chan T, Gelman RS, Whitney JB, O'Brien KL, Barouch DH, Goldstein DB, Haynes BF, Letvin NL. Contributions of Mamu-A*01 status and TRIM5 allele expression, but not CCL3L copy number variation, to the control of SIVmac251 replication in Indian-origin rhesus monkeys. Plos Genetics. 6: e1000997. PMID 20585621 DOI: 10.1371/Journal.Pgen.1000997  0.496
2010 Yeh WW, Rahman I, Hraber P, Coffey RT, Nevidomskyte D, Giri A, Asmal M, Miljkovic S, Daniels M, Whitney JB, Keele BF, Hahn BH, Korber BT, Shaw GM, Seaman MS, et al. Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys. Journal of Virology. 84: 6018-32. PMID 20357097 DOI: 10.1128/Jvi.02741-09  0.482
2010 Lim SY, Rogers T, Chan T, Whitney JB, Kim J, Sodroski J, Letvin NL. TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys. Plos Pathogens. 6: e1000738. PMID 20107597 DOI: 10.1371/Journal.Ppat.1000738  0.458
2010 Basavapathruni A, Yeh WW, Coffey RT, Whitney JB, Hraber PT, Giri A, Korber BT, Rao SS, Nabel GJ, Mascola JR, Seaman MS, Letvin NL. Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeys. Journal of Virology. 84: 953-63. PMID 19906933 DOI: 10.1128/Jvi.01679-09  0.502
2009 Whitney JB, Luedemann C, Hraber P, Rao SS, Mascola JR, Nabel GJ, Letvin NL. T-cell vaccination reduces simian immunodeficiency virus levels in semen. Journal of Virology. 83: 10840-3. PMID 19640980 DOI: 10.1128/Jvi.01202-09  0.548
2009 Whitney JB, Luedemann C, Bao S, Miura A, Rao SS, Mascola JR, Letvin NL. Monitoring HIV vaccine trial participants for primary infection: studies in the SIV/macaque model. Aids (London, England). 23: 1453-60. PMID 19550289 DOI: 10.1097/Qad.0B013E32832B43D9  0.413
2009 Mirshahidi S, Kramer VG, Whitney JB, Essono S, Lee S, Dranoff G, Anderson KS, Ruprecht RM. Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival. Vaccine. 27: 1825-33. PMID 19201387 DOI: 10.1016/J.Vaccine.2009.01.089  0.306
2009 Basavapathruni A, Yeh W, Coffey R, Whitney J, Hraber P, Giri A, Rao S, Mascola J, Nabel G, Korber B, Seaman M, Letvin N. P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P69  0.503
2009 Yeh W, Rahman I, Hraber P, Giri A, Nevidomskyte D, Coffey R, Asmal M, Miljkovic S, Whitney J, Keele B, Shaw G, Korber B, Seaman, Letvin N. P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys. Retrovirology. 6: 24. DOI: 10.1186/1742-4690-6-S3-P24  0.456
2008 Permar SR, Kang HH, Carville A, Mansfield KG, Gelman RS, Rao SS, Whitney JB, Letvin NL. Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys. Journal of Immunology (Baltimore, Md. : 1950). 181: 3643-50. PMID 18714039 DOI: 10.4049/Jimmunol.181.5.3643  0.386
2007 Whitney JB, Wainberg MA. Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genome. Retrovirology. 4: 44. PMID 17608929 DOI: 10.1186/1742-4690-4-44  0.58
2006 Whitney JB, Wainberg MA. Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIVmac239. Retrovirology. 3: 96. PMID 17184529 DOI: 10.1186/1742-4690-3-96  0.518
2006 Song RJ, Chenine AL, Rasmussen RA, Ruprecht CR, Mirshahidi S, Grisson RD, Xu W, Whitney JB, Goins LM, Ong H, Li PL, Shai-Kobiler E, Wang T, McCann CM, Zhang H, et al. Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. Journal of Virology. 80: 8729-38. PMID 16912320 DOI: 10.1128/Jvi.00558-06  0.531
2005 Wu Y, Hong K, Chenine AL, Whitney JB, Xu W, Chen Q, Geng Y, Ruprecht RM, Shao Y. Molecular cloning and in vitro evaluation of an infectious simian-human immunodeficiency virus containing env of a primary Chinese HIV-1 subtype C isolate. Journal of Medical Primatology. 34: 101-7. PMID 15860117 DOI: 10.1111/J.1600-0684.2005.00098.X  0.489
2004 Whitney JB, Ruprecht RM. Live attenuated HIV vaccines: pitfalls and prospects. Current Opinion in Infectious Diseases. 17: 17-26. PMID 15090885 DOI: 10.1097/00001432-200402000-00004  0.471
2004 Guo X, Hu J, Whitney JB, Russell RS, Liang C. Important role for the CA-NC spacer region in the assembly of bovine immunodeficiency virus Gag protein. Journal of Virology. 78: 551-60. PMID 14694086 DOI: 10.1128/Jvi.78.2.551-560.2004  0.459
2003 Liang C, Hu J, Whitney JB, Kleiman L, Wainberg MA. A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1. Journal of Virology. 77: 1772-83. PMID 12525611 DOI: 10.1128/Jvi.77.3.1772-1783.2003  0.577
2002 Whitney JB, Oliveira M, Detorio M, Guan Y, Wainberg MA. The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus. Journal of Virology. 76: 8958-62. PMID 12163615 DOI: 10.1128/Jvi.76.17.8958-8962.2002  0.575
2002 Whitney JB, Wainberg MA. Isoniazid, the frontline of resistance in mycobacterium tuberculosis McGill Journal of Medicine. 6: 114-123.  0.326
2001 Guan Y, Diallo K, Whitney JB, Liang C, Wainberg MA. An intact U5-leader stem is important for efficient replication of simian immunodeficiency virus. Journal of Virology. 75: 11924-9. PMID 11689678 DOI: 10.1128/Jvi.75.23.11924-11929.2001  0.555
2001 Guan Y, Diallo K, Detorio M, Whitney JB, Liang C, Wainberg MA. Partial restoration of replication of simian immunodeficiency virus by point mutations in either the dimerization initiation site (DIS) or Gag region after deletion mutagenesis within the DIS. Journal of Virology. 75: 11920-3. PMID 11689677 DOI: 10.1128/Jvi.75.23.11920-11923.2001  0.533
2001 Guan Y, Whitney JB, Detorio M, Wainberg MA. Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted. Journal of Virology. 75: 4056-67. PMID 11287555 DOI: 10.1128/Jvi.75.9.4056-4067.2001  0.581
2001 Guan Y, Whitney JB, Liang C, Wainberg MA. Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences. Journal of Virology. 75: 2776-85. PMID 11222701 DOI: 10.1128/Jvi.75.6.2776-2785.2001  0.609
2000 Guan Y, Whitney JB, Diallo K, Wainberg MA. Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus. Journal of Virology. 74: 8854-60. PMID 10982327 DOI: 10.1128/Jvi.74.19.8854-8860.2000  0.617
Show low-probability matches.